Page 180 - Veterinary Immunology, 10th Edition
P. 180

Produced by endothelial cells, resolvins and protectins promote
  VetBooks.ir  phagocyte removal by reducing neutrophil emigration from the

               bloodstream and enhancing macrophage ingestion of apoptotic
               neutrophils. Maresins are produced by macrophages and enhance

               tissue repair while acting on nerves to reduce pain. Lipoxins
               enhance macrophage activity while reducing neutrophil
               emigration. Chemokines are destroyed by tissue metalloproteases.
               Apoptotic neutrophils exercise negative feedback by releasing

               lactoferrin that suppresses neutrophil recruitment. Dying
               neutrophils attract scavengers. Thus phagocytosis of apoptotic
               neutrophils by macrophages promotes production of vascular
               endothelial growth factor (VEGF), a cytokine that is crucial for

               revascularization and wound repair. Once generated, M2 cells
               secrete SLP1, a serine protease inhibitor. This molecule inhibits the
               release of elastase and oxidants by TNF-α-stimulated neutrophils
               and inhibits the activity of the elastase. SLP1 also protects the

               antiinflammatory cytokine transforming growth factor-β (TGF-β)
               from breakdown, and TGF-β, in turn, inhibits the release of TNF-α.
                  Even in normal healthy animals, many cells die daily and must
               be promptly removed. This is the job of the macrophages. For

               example, dying neutrophils release the nucleotides adenosine
               triphosphate and uridine triphosphate. These attract macrophages
               that therefore move rapidly toward the apoptotic cells.
               Macrophages “palpate” any neutrophils that they encounter. If the

               neutrophil is healthy, the cells separate. If, however, the neutrophil
               is dead or dying, the macrophage remains in contact and eats the
               neutrophil. This interaction (efferocytosis) operates through CD31
               (Fig. 6.15). Thus CD31 on a neutrophil binds to CD31 on a

               macrophage. If the neutrophil is healthy, it sends a signal to the
               macrophage, causing it to disengage. On the other hand, if the
               neutrophil fails to signal, it will be eaten. It is interesting to note
               that this failure in CD31 signaling occurs long before a neutrophil

               begins to leak its enzyme contents and cause damage. Likewise the
               macrophages that consume these neutrophils do not release
               cytokines or vasoactive lipids. Ingestion of apoptotic neutrophils
               does, however, cause the macrophages to secrete more TGF-β,
               which in turn promotes tissue repair. Efferocytosis is thus an

               efficient way of removing apoptotic neutrophils without causing





                                                         180
   175   176   177   178   179   180   181   182   183   184   185